MktsMarkets

Bluejay Diagnostics, Inc.
NASDAQ: BJDXKey statistics
BJDX News
Stories mentioning BJDX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 812.00 | 585.00 | 786.00 | 890.00 | 785.00 | 553.00 | 552.00 | 1,032 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 1,939 | 1,462 | 1,617 | 1,985 | 1,889 | 1,485 | 1,362 | 1,895 |
| Operating Income (Loss) | (1,939) | (1,462) | (1,617) | (1,985) | (1,889) | (1,485) | (1,362) | (1,895) |
| Interest Income | 19.00 | 32.00 | 19.00 | 29.00 | 18.00 | 39.00 | 62.00 | 15.00 |
| Interest Expense | 186.00 | |||||||
| Other Expense | 1.00 | 0.00 | 1.00 | 0.00 | 7.00 | (11.00) | 9.00 | 31.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (1,919) | (1,429) | (1,598) | (1,957) | (1,864) | (1,433) | (1,482) | (2,475) |
| Earnings Per Share (Basic) | (1.95) | (3.18) | (1.01) | (1.41) | (13.46) | (31.15) | (76.94) | (256.16) |
| Earnings Per Share (Diluted) | (1.95) | (3.18) | (1.01) | (1.41) | (13.46) | (31.15) | (76.94) | (256.16) |
| Weighted Average Shares Outstanding (Basic) | 985.00 | 449.00 | 1,575 | 1,387 | 139.00 | 46.00 | 191.00 | 10.00 |
| Weighted Average Shares Outstanding (Diluted) | 985.00 | 449.00 | 1,575 | 1,387 | 139.00 | 46.00 | 191.00 | 10.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BJDX
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BJDX. It last traded at $0.5800 (Oct 23, 2026, 4:00 PM ET), down 7.0% on the day. That gives Bluejay Diagnostics a market capitalisation of $2.6M.
Over the past 52 weeks BJDX has traded between $0.5800 and $10.52.
For the quarter ended Mar 31, 2026 it reported a net loss of $1.9M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$1.9M |
| Dec 31, 2025 | — | -$1.4M |
| Sep 30, 2025 | — | -$1.6M |
| Jun 30, 2025 | — | -$2.0M |
From Bluejay Diagnostics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…